EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+6.51%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.95B
AUM Growth
+$137M
(+7.6%)
Cap. Flow
+$70.7M
Cap. Flow
% of AUM
3.63%
Top 10 Holdings %
Top 10 Hldgs %
62.7%
Holding
375
New
57
Increased
197
Reduced
86
Closed
22
Top Buys
| 1 |
Apple
AAPL
|
$12.2M |
| 2 |
Microsoft
MSFT
|
$12.2M |
| 3 |
NVIDIA
NVDA
|
$9.41M |
| 4 |
Broadcom
AVGO
|
$6.49M |
| 5 |
Pinduoduo
PDD
|
$5.98M |
Top Sells
| 1 |
ASE Group
ASX
|
$18.3M |
| 2 |
Sea Limited
SE
|
$11.3M |
| 3 |
TSMC
TSM
|
$9.44M |
| 4 |
ZTO Express
ZTO
|
$7.08M |
| 5 |
NIO
NIO
|
$4.53M |
Sector Composition
| 1 | Consumer Discretionary | 37.74% |
| 2 | Technology | 30.94% |
| 3 | Communication Services | 8.5% |
| 4 | Healthcare | 6.31% |
| 5 | Financials | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZH
251
Zhihu
ZH
$428M
| $317K | 0.02% |
+82,390
| New | +$317K |
|
252
Norfolk Southern
NSC
$62.3B
| $315K | 0.02% |
+1,268
| New | +$315K |
|
253
Seagate
STX
$40B
| $315K | 0.02% |
2,874
+616
| +27% | +$67.5K |
|
254
CVS Health
CVS
$93.6B
| $314K | 0.02% |
4,998
+276
| +6% | +$17.4K |
|
255
Cigna
CI
$81.5B
| $312K | 0.02% |
902
-48
| -5% | -$16.6K |
|
|
SOHU
256
Sohu.com
SOHU
$467M
| $312K | 0.02% |
+19,838
| New | +$312K |
|
257
PTC
PTC
$25.6B
| $310K | 0.02% |
1,715
+330
| +24% | +$59.6K |
|
258
Uber
UBER
$190B
| $308K | 0.02% |
4,100
-6,252
| -60% | -$470K |
|
259
Teledyne Technologies
TDY
$25.7B
| $305K | 0.02% |
698
+166
| +31% | +$72.7K |
|
260
Novavax
NVAX
$1.28B
| $305K | 0.02% |
24,121
+8,217
| +52% | +$104K |
|
261
HCA Healthcare
HCA
$98.5B
| $300K | 0.02% |
739
-72
| -9% | -$29.3K |
|
262
Teradyne
TER
$19.1B
| $300K | 0.02% |
2,239
+430
| +24% | +$57.6K |
|
263
Arcellx
ACLX
$4.03B
| $299K | 0.02% |
3,582
-1,630
| -31% | -$136K |
|
264
Beam Therapeutics
BEAM
$2.11B
| $294K | 0.02% |
12,020
+1,983
| +20% | +$48.6K |
|
265
Becton Dickinson
BDX
$55.1B
| $290K | 0.01% |
1,204
+39
| +3% | +$9.4K |
|
266
Recursion Pharmaceuticals
RXRX
$2.01B
| $286K | 0.01% |
43,418
+19,253
| +80% | +$127K |
|
|
SWTX
267
DELISTED
SpringWorks Therapeutics
SWTX
| $284K | 0.01% |
8,873
-594
| -6% | -$19K |
|
268
Take-Two Interactive
TTWO
$44.2B
| $284K | 0.01% |
1,849
+170
| +10% | +$26.1K |
|
269
Acadia Pharmaceuticals
ACAD
$4.26B
| $282K | 0.01% |
18,332
-196
| -1% | -$3.01K |
|
270
Nuvalent
NUVL
$5.83B
| $282K | 0.01% |
2,753
-1,176
| -30% | -$120K |
|
271
Amicus Therapeutics
FOLD
$2.46B
| $279K | 0.01% |
26,167
-1,567
| -6% | -$16.7K |
|
272
Immunovant
IMVT
$2.99B
| $279K | 0.01% |
9,789
+1,244
| +15% | +$35.5K |
|
273
Zebra Technologies
ZBRA
$16B
| $272K | 0.01% |
+734
| New | +$272K |
|
274
McKesson
MCK
$85.5B
| $269K | 0.01% |
545
+58
| +12% | +$28.7K |
|
275
Las Vegas Sands
LVS
$36.9B
| $269K | 0.01% |
5,345
| – | – |
|